Viewing Study NCT00700258


Ignite Creation Date: 2025-12-25 @ 12:11 AM
Ignite Modification Date: 2026-02-06 @ 6:42 AM
Study NCT ID: NCT00700258
Status: COMPLETED
Last Update Posted: 2024-09-23
First Post: 2008-06-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Renal Cell, Advanced View
None Lymphoma, Mantle-Cell View
None Gastrointestinal Stroma Tumors View
Keywords: